InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Explore the complete record of transactions filed by Huber Reid M, Director. Insider active across 4 companies, notably Bellicum Pharmaceuticals, INC. Cumulatively, 7 filings have been recorded. Split: 1 buy · 0 sell. Total volume traded: €426k. History available since 4 January 2022. The latest transaction was filed on 12 September 2025 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Reid M. Huber serves as a Board Member at Bellicum Pharmaceuticals, Inc. He plays a key role in the governance of the company, ensuring that strategic decisions align with the company's objectives. Reid Huber brings valuable expertise in the pharmaceutical field, contributing to growth and innovation at Bellicum Pharmaceuticals.